FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-807 | 70004-807-40 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-832 | 70004-832-40 | Potassium Chloride | 20 meq | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-833 | 70004-833-44 | Potassium Chloride | 40 meq | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-850 | 70004-850-12 | Rocuronium Bromide | 10 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-850 | 70004-850-09 | Rocuronium Bromide | 10 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | Succinylcholine Chloride | 20 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Succinylcholine Chloride | 20 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-900 | 70004-900-25 | Trisodium Citrate Dihydrate | 40 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-920 | 70004-920-59 | Vancomycin Hydrochloride | 1 g | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-923 | 70004-923-59 | Vancomycin Hydrochloride | 1.25 g | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-924 | 70004-924-59 | Vancomycin Hydrochloride | 1.5 g | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-924 | 70004-924-44 | Vancomycin Hydrochloride | 1.5 g | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-926 | 70004-926-44 | Vancomycin Hydrochloride | 1.75 g | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-928 | 70004-928-44 | Vancomycin Hydrochloride | 2 g | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-541 | 70004-541-35 | Diltiazem Hydrochloride | 1 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-540 | 70004-540-35 | Diltiazem Hydrochloride | 1 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-841 | 70004-841-40 | "potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic" | 15 mmol; 15 mmol | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-604 | 70004-604-12 | Ephedrine Sulfate | 5 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-604 | 70004-604-09 | Ephedrine Sulfate | 5 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-605 | 70004-605-09 | Ephedrine Sulfate | 10 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | Epinephrine | .032 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Epinephrine | .02 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Epinephrine | .008 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Epinephrine | .016 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-200 | 70004-200-16 | Fentanyl Citrate | .05 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-200 | 70004-200-32 | Fentanyl Citrate | .05 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-200 | 70004-200-17 | Fentanyl Citrate | .05 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-229 | 70004-229-32 | Fentanyl Citrate | .01 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-229 | 70004-229-40 | Fentanyl Citrate | .01 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-203 | 70004-203-32 | Fentanyl Citrate | .02 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-202 | 70004-202-22 | Fentanyl Citrate | .01 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-222 | 70004-222-30 | Fentanyl Citrate | .05 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-200 | 70004-200-06 | Fentanyl Citrate | .05 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-251 | 70004-251-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; .75 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-289 | 70004-289-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; 4 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-254 | 70004-254-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-253 | 70004-253-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-244 | 70004-244-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; .625 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-264 | 70004-264-22 | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-260 | 70004-260-32 | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-638 | 70004-638-09 | Glycopyrrolate | .2 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-21 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-17 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-16 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-22 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-55 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-62 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2022-2 | valid | 2026-11-10 |